FDA Approves Nivolumab with Chemotherapy for Previously Untreated Hodgkin Lymphoma By Ogkologos - April 1, 2026 189 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Study CA209-8UT (SWOG 1826) Source RELATED ARTICLESMORE FROM AUTHOR Patient Guide in Soft Tissue Sarcoma Now Available Also in Ukrainian Adjuvant Pembrolizumab Continues to Demonstrate Benefit in DFS and OS Among Patients with ccRCC ESMO Welcomes European Parliament (EP) report on Psychosocial Risks (PSR) at Work as a Key Step towards Protecting the Cancer Workforce and Ensuring High-Quality... MOST POPULAR Former WNBA Player, Current Georgia Tech Coach Tasha Butts Diagnosed with... December 14, 2021 Tackling under-representation of Black data scientists in cancer research November 7, 2022 What is De-escalation Treatment in Cancer Research? May 30, 2023 Beauty, Healing and Space January 27, 2021 Load more HOT NEWS What to Know About Returning to Work After Cancer Treatment: An... Exposure to Antibiotics, Specifically Fluoroquinolones, Before Treatment with Immune Checkpoint Inhibitor... Understanding Serving Sizes ESMO Calls for Cancer Care Integration in EU Global Health Resilience...
